Abiopharma

News list

Sonnet BioTherapeutics Holdings Inc. (SONN)

Business News
Aug. 04, 2025, 12:40 UTC

Sonnet BioTherapeutics Expands Clinical Evaluation of SON-1010 Dose Escalation with Atezolizumab in Ovarian Cancer

Full text

Register to leave comments
There are no comments here yet...